Market Research Industry Reports

Otonomy, Inc. (OTIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Otonomy, Inc. (Otonomy) is a clinical stage biopharmaceutical company that develops and commercializes treatments for unmet diseases in the field of otology. The companys otiprio is a fluoroquinolone antibacterial that is useful for the treatment of pediatric patients. Its product candidates include OTO-104, OTO-311 and OTO-4XX. Otonomys OTO-104 is a formulation of the steroid dexamethasone under development for the treatment of Menieres disease and other inner ear conditions; and OTO-311 is an antagonist gacyclidine under development for the treatment of tinnitus. The company develops new drug therapies for the treatment of debilitating hearing and balance disorders. It undertakes clinical trial of several drugs. Otonomy is headquartered in San Diego, California, the US.

Otonomy, Inc. (OTIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 3
List of Figures 4
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Otonomy, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Otonomy, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Otonomy Acquires Assets and Patent Rights From NeuroSystec 11
Venture Financing 12
Otonomy Raises US$49 Million In Series D Venture Financing 12
Otonomy Raises US$46 Million In Series C Venture Financing 15
Otonomy Secures US$38.5 Million In Series B Venture Financing 17
Otonomy Completes Series A Financing For US$10 Million 19
Licensing Agreements 20
Otonomy Enters into Licensing Agreement with Ipsen 20
Otonomy Enters into Licensing Agreement with Durect 21
Equity Offering 23
Otonomy Raises USD115 Million in Public Offering of Shares 23
Otonomy Raises USD86 Million in Public Offering of Shares 25
Otonomy Completes Underwriters Exercise of Over-Allotment Option of IPO for USD115 Million 27
Otonomy, Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List Of Tables


Otonomy, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Otonomy, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Otonomy, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Otonomy Acquires Assets and Patent Rights From NeuroSystec 11
Otonomy Raises US$49 Million In Series D Venture Financing 12
Otonomy Raises US$46 Million In Series C Venture Financing 15
Otonomy Secures US$38.5 Million In Series B Venture Financing 17
Otonomy Completes Series A Financing For US$10 Million 19
Otonomy Enters into Licensing Agreement with Ipsen 20
Otonomy Enters into Licensing Agreement with Durect 21
Otonomy Raises USD115 Million in Public Offering of Shares 23
Otonomy Raises USD86 Million in Public Offering of Shares 25
Otonomy Completes Underwriters Exercise of Over-Allotment Option of IPO for USD115 Million 27
Otonomy, Inc., Key Competitors 29
Otonomy, Inc., Key Employees 30

List Of Figures


Otonomy, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Otonomy, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Otonomy, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Otonomy, Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Otonomy, Inc. (OTIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Otonomy, Inc. (Otonomy) is a clinical stage biopharmaceutical company that develops and commercializes treatments for unmet diseases in the field of otology. The companys otiprio is a fluoroquinolone antibacterial that

USD 250View Report

Otonomy, Inc. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Otonomy, Inc. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2016
No. of Pages :32
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube